CytoDyn Inc (CYDY)
0.147
+0.01
(+5.76%)
USD |
OTCM |
May 03, 16:00
CytoDyn Max Drawdown (5Y): 98.42% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 98.42% |
March 31, 2024 | 98.27% |
February 29, 2024 | 98.27% |
January 31, 2024 | 98.27% |
December 31, 2023 | 98.27% |
November 30, 2023 | 98.27% |
October 31, 2023 | 98.22% |
September 30, 2023 | 98.00% |
August 31, 2023 | 97.83% |
July 31, 2023 | 97.83% |
June 30, 2023 | 97.83% |
May 31, 2023 | 97.83% |
April 30, 2023 | 97.83% |
March 31, 2023 | 97.83% |
February 28, 2023 | 97.83% |
January 31, 2023 | 97.83% |
December 31, 2022 | 97.83% |
November 30, 2022 | 97.26% |
October 31, 2022 | 97.26% |
September 30, 2022 | 97.26% |
August 31, 2022 | 97.26% |
July 31, 2022 | 97.26% |
June 30, 2022 | 97.26% |
May 31, 2022 | 97.26% |
April 30, 2022 | 97.26% |
Date | Value |
---|---|
March 31, 2022 | 95.81% |
February 28, 2022 | 94.90% |
January 31, 2022 | 94.30% |
December 31, 2021 | 88.81% |
November 30, 2021 | 87.23% |
October 31, 2021 | 85.75% |
September 30, 2021 | 85.46% |
August 31, 2021 | 85.40% |
July 31, 2021 | 84.77% |
June 30, 2021 | 84.77% |
May 31, 2021 | 84.77% |
April 30, 2021 | 84.77% |
March 31, 2021 | 84.77% |
February 28, 2021 | 84.77% |
January 31, 2021 | 84.77% |
December 31, 2020 | 84.77% |
November 30, 2020 | 84.77% |
October 31, 2020 | 84.77% |
September 30, 2020 | 84.77% |
August 31, 2020 | 84.77% |
July 31, 2020 | 84.77% |
June 30, 2020 | 84.77% |
May 31, 2020 | 84.77% |
April 30, 2020 | 84.77% |
March 31, 2020 | 84.77% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
84.77%
Minimum
Jun 2019
98.42%
Maximum
Apr 2024
90.90%
Average
87.48%
Median
Max Drawdown (5Y) Benchmarks
NovaBay Pharmaceuticals Inc | 99.91% |
Palatin Technologies Inc | 96.46% |
iBio Inc | 99.97% |
Theriva Biologics Inc | 99.81% |
Oragenics Inc | 98.92% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -24.76 |
Beta (5Y) | 0.2539 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 165.9% |
Historical Sharpe Ratio (5Y) | -0.1322 |
Historical Sortino (5Y) | -0.4992 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 38.06% |